- Conditions: Asthma; Panic Disorder
Interventions: Behavioral: Music Relaxation Therapy (MRT); Behavioral: Cognitive Behavioral Therapy (CBT) and heart rate variability biofeedback
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4; Other: Placebo DPI; Drug: Flovent Diskus 250 mcg
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Not yet recruiting - verified May 2012 - Condition: Food Hypersensitivity
Interventions: Other: Amino Acid formula; Other: Commercially available Amino Acid Formula
Sponsors: Nestlé Nutrition Corporate; Nestlé Nutrition Corporate
Not yet recruiting - verified April 2012 - Condition: Asthma
Intervention: Other: Environmental Intervention
Sponsors: Columbia University; Columbia University; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Allergic Contact Dermatitis
Intervention: Other: Patch tests
Sponsors: Rockefeller University; Rockefeller University
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg; Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 50 mcg; Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg; Drug: Mometasone Furoate (MF) Dry Powder Inhaler (DPI), 100 mcg; Drug: Placebo Metered Dose Inhaler (MDI); Drug: Placebo Dry Powder Inhaler (DPI)
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Flovent Diskus; Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries; PPD
Recruiting - verified May 2012 - Conditions: Childhood Asthma; Oxidative Stress
Intervention:
Sponsors: Stony Brook University; Stony Brook University
Recruiting - verified November 2011 - Condition: Asthma
Interventions: Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg; Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg; Drug: Mometasone Furoate MDI 100 mcg; Drug: Mometasone Furoate MDI 200 mcg; Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI; Drug: Prednisone/prednisolone
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Conditions: Atopic Dermatitis; Eczema Herpeticum
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Peanut Allergy
Interventions: Drug: QGE031; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified March 2012 - Conditions: Perennial Allergic Rhinitis; PAR
Interventions: Drug: Ciclesonide nasal aerosol 37 mcg; Drug: ciclesonide nasal aerosol 74 mcg; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified March 2012 - Conditions: Asthma; Psychosocial Stress
Interventions: Behavioral: Stress management program; Other: Peer viewed movies
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified September 2011 - Conditions: Sickle Cell Disease; Vitamin D Deficiency; Acute Chest Syndrome; Asthma; Respiratory Infections
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: Columbia University; Columbia University
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: Symbicort pMDI; Drug: Symbicort pMDI; Drug: budesonide pMDI; Drug: budesonide pMDI
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Fluticasone furoate 50mcg; Drug: Fluticasone propionate 100mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Fluticasone/Salmeterol Diskus; Drug: Fluticasone/Salmeterol Diskus; Drug: Fluticasone Diskus
Sponsors: Johns Hopkins University; Johns Hopkins University; American Lung Association; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Biological: Omalizumab; Drug: Fluticasone; Other: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Asthma
Intervention: Other: Pictogram-based asthma action plan
Sponsors: New York University School of Medicine; New York University School of Medicine; Feinberg School of Medicine, Northwestern University
Recruiting - verified July 2011 - Condition: Asthma
Intervention: Drug: Tralokinumab
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Flovent Diskus, Advair Diskus, Ventolin HFA, cetirizine, Flonase Nasal Spray, Singulair
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Condition: ACE Inhibitor Induced Angioedema
Interventions: Drug: ecallantide; Drug: ecallantide; Drug: ecallantide; Drug: placebo
Sponsors: Dyax Corp.; Dyax Corp.
Recruiting - verified April 2012 - Conditions: Esophagitis; Eosinophilic Esophagitis
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified May 2012 - Conditions: Asthma; Obesity; Inflammation
Interventions: Drug: Montelukast; Drug: Placebo; Drug: Montelukast; Drug: Placebo
Sponsors: North Shore Long Island Jewish Health System; North Shore Long Island Jewish Health System; Thrasher Research Fund; Merck
Recruiting - verified January 2012 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsors: Cephalon; Cephalon
Recruiting - verified April 2012 - Condition: Food Hypersensitivity
Interventions: Other: Extensively hydrolyzed, whey protein infant formula; Other: Extensively hydrolyzed, casein protein infant formula
Sponsors: Nestlé Nutrition Corporate; Nestlé Nutrition Corporate
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Tiotropium; Drug: Salmeterol; Drug: Formoterol
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Olmsted Medical Center; American Academy of Family Physicians National Research Network; Harvard Clinical Research Institute
Recruiting - verified March 2012 - Condition: Dermatitis
Interventions: Biological: REGN668; Biological: REGN668; Biological: REGN668
Sponsors: Regeneron Pharmaceuticals; Regeneron Pharmaceuticals; Sanofi-Aventis
Recruiting - verified February 2012 - Condition: Milk Allergy
Interventions: Biological: Xolair® (omalizumab) placebo/milk OIT; Biological: Xolair® (omalizumab)/milk OIT
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: Atopic Dermatitis; Eczema
Intervention: Drug: Cyclosporine A
Sponsors: Rockefeller University; Rockefeller University
Recruiting - verified February 2012 - Conditions: Asthma; Rhinitis; Sinusitis
Interventions: Drug: Mometasone Furoate monohydrate; Other: Placebo
Sponsors: American Lung Association Asthma Clinical Research Centers; American Lung Association Asthma Clinical Research Centers; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2011 - Condition: Asthma
Intervention: Behavioral: Multifaceted Prompting Intervention MPI
Sponsors: University of Rochester; University of Rochester; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2011 - Condition: Includes: Hereditary Angioedema
Intervention: Biological: Berinert® (C1 Esterase Inhibitor)
Sponsors: CSL Behring; CSL Behring; Chiltern International Inc.
Recruiting - verified May 2012 - Condition: Tumor Lysis Syndrome
Intervention:
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: Imatinib mesylate; Drug: Placebo
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Harvard Clinical Research Institute; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
Sponsors: Dyax Corp.; Dyax Corp.
Recruiting - verified April 2012 - Conditions: Wheezing; Asthma; Allergy
Interventions: Biological: Allergen extracts (subcutaneous injections); Other: Standard of care
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; Jacobi Medical Center
Recruiting - verified June 2011 - Condition: Asthma
Intervention: Behavioral: Wee Wheezers
Sponsors: Montefiore Medical Center; Montefiore Medical Center; American Lung Association
Recruiting - verified July 2011 - Conditions: Deglutition Disorders; Esophageal Diseases; Eosinophilia
Intervention: Other: assessment of disease activity using the EEsAI
Sponsors: University Hospital Inselspital, Berne; University Hospital Inselspital, Berne; Institute of Social and Preventive Medicine, University Bern; Dept. of Gastroenterology, Kantonsspital Olten, Olten; Luzerner Kantonsspital; Mayo Clinic Rochester, Minnesota, USA; University of Cincinnati; University of Colorado, Denver; Northwestern University of Chicago, Illinois, USA; Indiana University School of Medicine; Philadelphia University
Recruiting - verified March 2012 - Conditions: Hypertension; Asthma
Interventions: Other: PPCM Asthma; Other: 24 Month PPCM BP; Other: 9 Month PPCM HTN
Sponsors: University of Iowa; University of Iowa
Recruiting - verified June 2010 - Condition: Asthma
Interventions: Drug: Levalbuterol; Drug: Levalbuterol UDV TID; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified February 2012 - Condition: Atopic Dermatitis
Intervention:
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified March 2012 - Conditions: Asthma; COPD; Interstitial Lung Disease; Cystic Fibrosis; Lung Cancer
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Conditions: Lung Disease; Bronchitis; Emphysema; COPD; Asthma
Interventions: Procedure: Bronchopulmonary Lung Lavage; Procedure: Bronchial Brushing; Procedure: Bronchial Wall Biopsy
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Asthma
Intervention:
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified November 2006
 |
Join Clinical Trials in New York for Allergies |
